Cite

HARVARD Citation

    Donovan, K. et al. (2023). Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases. Clinical journal of the American Society of Nephrology. 18 (1), pp. 17-27. [Online]. 
  
Back to record